Espoo, Finland

Tatu Miettenen


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1999-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tatu Miettenen: Innovator in Cholesterol-Lowering Substances

Introduction

Tatu Miettenen is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of health and nutrition, particularly in developing substances that help lower cholesterol levels. With a total of 5 patents to his name, Miettenen's work has the potential to impact many lives positively.

Latest Patents

One of Miettenen's latest patents focuses on a substance for lowering high cholesterol levels in serum. This invention relates to a fat-soluble β-sitostanol fatty acid ester, which has been shown to lower LDL cholesterol levels. The substance can be consumed orally as a food additive, food substitute, or supplement. Daily consumption of the β-sitostanol ester in amounts ranging from about 0.2 to about 20 g/day has demonstrated effectiveness in reducing the absorption of biliary and endogenous cholesterol.

Career Highlights

Throughout his career, Tatu Miettenen has worked with prominent companies in the nutrition sector, including Raisio Benecol Ltd. and Raisio Nutrition Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in dietary health.

Collaborations

Miettenen has collaborated with several professionals in his field, including Ingmar Wester and Hannu Vanhanen. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Tatu Miettenen is a distinguished inventor whose work in cholesterol-lowering substances showcases his commitment to improving health through innovation. His contributions are significant in the field of nutrition and have the potential to benefit many individuals seeking to manage their cholesterol levels effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…